Start for free
Start for free
Janchor Partners logo

Janchor Partners

Asia, Hong Kong Island, Hong Kong, Central

Description

Janchor Partners is a long‐term industrialist investor, partnering with companies that have superior business models.

Investor Profile

Janchor Partners has made 6 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series D (33%)
  • Series C (33%)
  • Private Equity (17%)
  • Series A (17%)

Country Focus

  • China (67%)
  • United States (17%)
  • India (17%)

Industry Focus

  • Health Care
  • Pharmaceutical
  • Biotechnology
  • Therapeutics
  • Biopharma
  • Medical
  • Credit Cards
  • Finance
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Janchor Partners frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 4
CICC
CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
GB
Greater Bay Area Homeland Development Fund
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Hudson Bay Capital Management
Hudson Bay Capital Management
North America, New York, United States, New York
Co-Investments: 2
Lake Bleu Capital
Lake Bleu Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3
Octagon Capital Advisors
Octagon Capital Advisors
North America, New York, United States, New York
Co-Investments: 2
Qiming Venture Partners
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
HC
Hankang Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Vivo Capital
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Lilly Asia Ventures
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 4

What are some of recent deals done by Janchor Partners?

FPL Technologies

Pune, Maharashtra, India

FPL is on a mission to re-imagine credit and payments from first principles and is building a mobile-first credit card.

Credit CardsFinanceFinancial ServicesFinTech
Series CDec 30, 2021
Amount Raised: $75,000,000
Abbisko Therapeutics

Shanghai, Shanghai, China

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

Health CarePharmaceuticalTherapeutics
Series DJan 7, 2021
Amount Raised: $123,000,000
InventisBio

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical
Series DSep 27, 2020
Amount Raised: $147,000,000
Everest Medicines

New York, New York, United States

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

BiotechnologyHealth CarePharmaceutical
Series CJun 3, 2020
Amount Raised: $310,000,000
Remegen

Yantai, Liaoning, China

Remegen is a biotech company focused on discovering and developing a new generation of targeted therapies for the treatments of cancer.

BiotechnologyHealth CareTherapeutics
Private EquityMar 17, 2020
Amount Raised: $100,000,000
Rongchang Pharmaceutical

Yantai, Liaoning, China

Rongchang Pharmaceutical is a health care Company.

Health CareMedicalPharmaceutical
Series AMar 16, 2020
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator